Completing the map of the human genome set all research, drug development, and diagnostics on a new and exciting course. Randall Dishmon discusses where he sees investment opportunity in this emerging field.
Leave a commentKristina Hooper assesses where the U.S. Federal Reserve appears to be making progress toward some of its goals and which issues are beyond the reach of central bank intervention.
Comments Off on Is everything going according to plan?
Equity strategist Talley Léger explores a tail risk scenario for markets — the probability of which may be increasing.
Comments Off on Are stocks already sniffing out an economic recession?
Brian Levitt goes back to 1995 and examines how different responses to market turmoil would have impacted a $100,000 investment in the U.S. stock market.
Comments Off on Responding to downturns: What history tells us about perseverance
Markets are confused about how aggressive the Fed may get this year, so we’ve seen the ugly month of April continue into May. But Kristina Hooper believes there’s light at the end of the tunnel.
Comments Off on Markets struggle to adjust in the face of Fed uncertainty
During the six U.S. Federal Reserve tightening cycles since 1983, U.S. large-cap growth stocks outperformed during four of them. Darim Abdullah, Vice President – ETF Strategist, explores the Nasdaq 100 Index over the past decade and the most recent tightening cycle.
Comments Off on Examining U.S. large-cap performance in Fed tightening cycles
